Primary record
1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-
- 库存
- 7,081 克
- 纯度
- 98.7 %
- CAS
- 250384-82-8
化合物标识与属性
- CAS
- 250384-82-8
- PubChem CID
- 10672195
- SMILES
- C[C@H](C/C=C/S(=O)(=O)C(C)(C)C)C1=CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
- Canonical SMILES
- C=C1/C(=C\C=C2/CCC[C@]3(C)C([C@H](C)C/C=C/S(=O)(=O)C(C)(C)C)=CC[C@@H]23)C[C@@H](O)C[C@@H]1O
名称与同义词
- Lunacalcipol
- lunacalcipolum
- Lunacalcipol [USAN]
- CTA018
- Lunacalcipol [USAN:INN]
- UNII-XN4TL6M50Z
- CTA-018
- XN4TL6M50Z
- LUNACALCIPOL [INN]
- CTA 018
- RefChem:800130
- Lunacalcipol (USAN/INN)
- D00DYK
- LUNACALCIPOL [WHO-DD]
- 250384-82-8
- orb1696307
- CTA018/MT2832
- CHEMBL2105705
- SCHEMBL29376374
- GTPL11382
- CHEBI:177662
- GH-1623E-diene-25SO2-2
- BDBM50023361
- AKOS040752736
- MT-2832
- CID10672195
- CID 10814396
- HY-14863
- CS-0003602
- (1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulfonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- J1.180.657K
- D09928
- Q27293916
- Lunacalcipol (intravenous, secondary hyperparathyroidism)
- CTA-018 (intravenous, secondary hyperparathyroidism), Cytochroma
- Lunacalcipol (intravenous, secondary hyperparathyroidism), Cytochroma
- (5Z,7E,16Z,23E)-(1S,3R)-25-nor-25-t-Butylsulfonyl-9,10-seco-5,7,10(19),16,23- cholestapentaene-1,3-diol
- 1,3-Cyclohexanediol, 5-((2E)-2-((3aS,7aS)-1-((1R,3E)-4-((1,1-dimethylethyl)sulfonyl)-1- methyl-3-buten-1-yl)-3,3a,5,6,7,7a-hexahydro-7a-methyl-4H-inden-4- ylidene)ethylidene)-4-methylene-, (1R,3S,5Z)-
- Vitamin D analogs (secondary hyperparathyroidism), Johns Hopkins/Cytochroma
- CYP24 inhibitors (intravenous, secondary hyperparathyroidism), Johns Hopkins/Cytochroma
- (1R,3S,5Z)-5-((2E)-2-((3aS,7aS)-1-((E,2R)-5-tert-butylsulfonylpent-4-en-2-yl)-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene)ethylidene)-4-methylidenecyclohexane-1,3-diol
- (1R,3S,5Z)-5-[(2E)-2-[(3aS,7aS)-1-[(E,2R)-5-tert-butylsulonylpent-4-en-2-yl]-7a-methyl-3a,5,6,7-tetrahydro-3H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
- (1R,3S,5Z)-5-{2-[(3aS,7E,7aS)-3a-methyl-3-[(2R,4E)-5-(2-methylpropane-2-sulfonyl)pent-4-en-2-yl]-3a,4,5,6,7,7a-hexahydro-1H-inden-7-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol
- (5Z,7E,16Z,23E)-(1S,3R)-25-NOR-25-T-BUTYLSULFONYL-9,10-SECO-5,7,10(19),16,23-CHOLESTAPENTAENE-1,3-DIOL
- (5Z,7E,16Z,23E)-24-((1,1-Dimethylethyl)sulfonyl)-9,10-secochola-5,7,10(19),16,23- pentaene-1alpha,3beta-diol
- (5Z,7E,23E)-25,26,27-Trinor-24-(tert-butylsulfonyl)-9,10-secocholesta-5,7,10(19),16,23-pentene-1alpha,3beta-diol
- (5Z,7E,23E)-4-Methylene-24-(tert-butylsulfonyl)-19-nor-9,10-secochola-5,7,16,23-tetraene-1alpha,3beta-diol
- 1,3-CYCLOHEXANEDIOL, 5-((2E)-2-((3AS,7AS)-1-((1R,3E)-4-((1,1-DIMETHYLETHYL)SULFONYL)-1-METHYL-3-BUTEN-1-YL)-3,3A,5,6,7,7A-HEXAHYDRO-7A-METHYL-4H-INDEN-4-YLIDENE)ETHYLIDENE)-4-METHYLENE-, (1R,3S,5Z)-